Neuromyelitis optica spectrum disorders, terminology and therapeutic issues: amended consensus opinion

In Russian Federation in 2022, the Expert Council adopted the main definitions and terms for neuromyelitis optica spectrum disorders (NMOSD) and proposed a treatment algorithm for patients with NMOSD with antibodies to aquaporin-4 (AQP4-IgG). The publication is intended to present the results of the work of the Russian Expert Council in September 2024. The experts agreed on clarifications of previously published terminology, new definitions, current issues in the therapy of NMOSD, proposed profiles of patients with NMOSD for ravulizumab and a monitoring plan during treatment with this drug, and agreed on an updated algorithm for prescribing medications that prevent exacerbations in patients with NMOSD with AQP4-IgG aged 18 years and older.

Authors

Institutions

Publication Details

Journal
Neurology neuropsychiatry Psychosomatics
Published
2024-12-18
DOI
https://doi.org/10.14412/2074-2711-2024-6-134-143
Citations
1
Primary Topic
Multiple Sclerosis Research Studies
Type
article
Field-Weighted Citation Impact
0.42
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Neuromyelitis optica spectrum disorders, terminology and therapeutic issues: amended consensus opinion

M. V. Shumilina, M. V. Davydovskaia, M. D. Matson, D. S. Korobko et al.
1 citations
Neurology neuropsychiatry Psychosomatics
Multiple Sclerosis Research Studies
0.42
article

Neuromyelitis optica spectrum disorders, terminology and therapeutic issues: amended consensus opinion

M. V. Shumilina, M. V. Davydovskaia, M. D. Matson, D. S. Korobko, A. I. Nilov, Н. В. Хачанова, В. С. Краснов, E. P. Evdoshenko, I. V. Vlasov, N. А. Totolyan, A. A. Sokolova
article en
1 citations

Abstract

In Russian Federation in 2022, the Expert Council adopted the main definitions and terms for neuromyelitis optica spectrum disorders (NMOSD) and proposed a treatment algorithm for patients with NMOSD with antibodies to aquaporin-4 (AQP4-IgG). The publication is intended to present the results of the work of the Russian Expert Council in September 2024. The experts agreed on clarifications of previously published terminology, new definitions, current issues in the therapy of NMOSD, proposed profiles of patients with NMOSD for ravulizumab and a monitoring plan during treatment with this drug, and agreed on an updated algorithm for prescribing medications that prevent exacerbations in patients with NMOSD with AQP4-IgG aged 18 years and older.

Neurology neuropsychiatry PsychosomaticsVol. 16(6)
First Pavlov State Medical University of St. Petersburg (RU), Ministero della Salute (IT), Pirogov Russian National Research Medical University (RU), Ministry of Health of the Russian Federation (RU), Samara State Medical University (RU), City Clinical Hospital (RU), City Clinical Hospital No. 2 (RU), Samara Regional Clinical Hospital named after V.D. Seredavina (RU), Tula Regional Clinical Hospital (RU), Khanty-Mansiysk State Medical Academy (RU)
Good health and well-being
Openalex Percentile: Top 31%
Multiple Sclerosis Research Studies
0.42
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.